Idazoxan produced small increases in dopamine release in the nucleus accumbens (not so good, maybe) and frontal cortex (that's the ticket), and augmented the increase produced by risperidol.
Though, risperidol also blocks α 2 adrenoceptors, so this augmentation may be due to additional α 2 antagonism.